17 Apr 2019 World Vaccine Congress (USA)
GPN Vaccines’ Chairman & CEO gives presentation on “A new serotype-independent pneumococcal vaccine” at the World Vaccine Congress (USA) in Washington DC....
News
22 Feb 2019 Professor Helen Marshall joins GPN Vaccines’ Scientific & Advisory Board
Prof Marshall has been an investigator on more than 50 paediatric, adolescent and adult clinical trials including studies on influenza, pertussis, meningococcal and human Papillomavirus vaccines. [Press Release]...
03 Feb 2019 Capital raise sparks news interest in GPN Vaccines
"New pneumonia jab hope" [Adelaide Advertiser Sunday Mail]...
18 Jan 2019 GPN Vaccines raises AUD$1.1M (USD$0.8M)
GPN Vaccines has completed a fully subscribed AUD$1.1 million (USD$0.8 million) capital raising towards development of its proprietary vaccine, Gamma-PN. [Download]...
31 Oct 2018 World Vaccine Congress (Europe)
GPN Vaccines' Chairman & CEO gives presentation on "A new serotype-independent pneumococcal vaccine" at the World Vaccine Congress (Europe) in Lisbon, Portugal...
15 Jun 2018 Patent granted in South Africa
GPN Vaccines’ “Streptococcal Vaccine” patent granted in South Africa....